CytoSorbents

CytoSorbents Corporation is a critical care focused immunotherapy company using blood purification t

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology. CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery. CytoSorbents has multiple active, clinical trials ongoing, including two pivotal randomized, controlled trials in the United States designed to support eventual FDA marketing approval for antithrombotic removal during cardiothoracic surgery using the DrugSorb™-ATR Antithrombotic Removal System.

12/01/2025

🎄December is here, and so is the moment when even the most disciplined professionals suddenly develop a surprising talent for opening tiny doors at breakfast. Our Advent Calendar celebrates this season with daily insights, small surprises and thoughtful moments from across our medical community.
Join us each day and discover what we have prepared.
Follow the link and open today’s door of the CytoSorbents Advent Calendar.
👉 https://cyto.news/adventcalendar

11/27/2025

🎥 Watch more voices here: https://cytosorbents.com/voices/

11/27/2025

Thanksgiving Greeting 🦃

Wishing everyone a very Happy Thanksgiving. We are grateful for our colleagues, partners, customers and the continued support throughout the year. Enjoy a safe and joyful holiday!

11/27/2025

Rückblick auf unseren Roundtable in Oldenburg

Der Roundtable in Oldenburg bot eine hervorragende Plattform für den fachlichen Austausch. In intensiven Gesprächen konnten wir aktuelle Herausforderungen, Erfahrungen aus dem Alltag und konkrete Therapieansätze diskutieren – gemeinsam mit engagierten Expertinnen und Experten aus der Region.

Ein herzliches Dankeschön an alle Teilnehmenden für die wertvollen Beiträge, die offene Diskussion und das Interesse. Solche Dialogformate zeigen, wie wichtig kontinuierlicher Wissensaustausch für eine bestmögliche Patientenversorgung ist.

11/26/2025

A strong finish to an intensive year at CytoSorbents Europe

Our Direct International Sales Meeting brought colleagues from across Europe together at our Berlin headquarters for two days of focused exchange, shared insights, and aligned priorities for the months ahead.

Beyond the strategic discussions, it was the personal connections that stood out. The joint visit to the Berlin Christmas market provided the perfect setting to reflect on achievements, strengthen our collaboration, and look ahead with renewed energy.

Bringing teams together across countries and departments continues to be a cornerstone of our success. Thank you to everyone who contributed to these productive and inspiring days.

11/26/2025

Vom 3. bis 5. Dezember 2025 trifft sich die Intensiv- und Notfallmedizin zur DIVI e.V. Jahrestagung 2025 im Congress Center Hamburg.

CytoSorbents ist vor Ort, um über die Rolle der Hämoadsorption in der Intensivmedizin zu sprechen – von der Behandlung schwerer Entzündungsreaktionen bis hin zur Unterstützung von Organfunktionen bei kritisch kranken Patient:innen.

Treffen Sie unser Team in Hamburg und tauschen Sie sich mit uns über aktuelle klinische Erfahrungen, neue wissenschaftliche Erkenntnisse und innovative Ansätze in der Intensivtherapie aus.

Am Mittwoch und am Donnerstag, jeweils um 10 Uhr in der Ausstellungshalle, haben wir außerdem zwei Campfire für Sie organisiert zu den Themen "Hemoadsorption bei der Behandlung des septischen Schocks – Machen wir schon alles richtig?" mit Prof. Steffen Mitzner und Dr. Klaus Kogelmann, sowie "S3 Leitlinie kritisch hinterfragt – Was wird aus der individuellen Patientenbehandlung?" mit Dr. Moritz Unglaube und Dr. Daniel Gill-Schuster.

Wir freuen uns auf inspirierende Gespräche und den Austausch mit der DIVI-Community!

11/25/2025

Nicht verpassen: Webinar „Wie dokumentiere & kodiere ich richtig?“ am 26. November!

Sichern Sie sich wertvolle Tipps und Antworten auf Ihre Fragen zur korrekten Dokumentation und Kodierung im stationären Bereich – direkt von erfahrenen Referenten.

Jetzt noch schnell anmelden und dabei sein!https://cyto.news/medcon/nov2025
Wir freuen uns auf Ihre Teilnahme.

11/21/2025

⏳Every minute counts in a stroke - but it took decades to prove clot-busting drugs could help.

For decades, stroke was seen as untreatable. Early trials of thrombolysis raised fears of brain bleeding. Many doctors doubted it would ever work.

In 1995, the NINDS trial showed that tPA, given within 3 hours, improved recovery. Yet many hospitals hesitated, worried about risks. Only with specialized Stroke Units, rapid imaging, and strict protocols did thrombolysis become reliable.

Step by step, evidence and experience transformed skepticism into confidence. Today, thrombolysis is routine worldwide.
👉 Proven therapies still need practice and refinement before becoming standard.

has followed a similar path-growing stronger with evidence and experience.
Read more in our blog ‘Every Innovation Has a Learning Curve’, and visit our Literature Database and Voices Around the World for real-life evidence and experience with CytoSorb.

11/21/2025

It is a pleasure to host our Sales Meeting Germany at the CytoSorbents European headquarters in Berlin together with Dr. Phillip P. Chan (CEO), Dr. Christian Steiner (EVP Sales & Marketing, Co-Managing Director CytoSorbents Europe GmbH) and Peter J. Mariani (CFO).

The exchange offered valuable insights into current developments and strengthened the collaboration between our German team and global leadership.
Many thanks to everyone involved for the constructive discussions and the continued commitment that drives our work forward.

11/19/2025

When women in tech meet purpose in medicine.

At Web Summit 2025 in Lisbon, women from around the world connect to shape the future of technology and healthcare. From AI and digital innovation to real-world impact — it’s about creating space for diverse voices and new ideas. Representing CytoSorbents in this community means bringing our passion for digital transformation to a global stage.

11/18/2025

„Klug entscheiden“ – das Motto des diesjährigen DIVI-Kongresses passt perfekt zu den Herausforderungen unserer Zeit:
Patientenversorgung bedeutet, wissenschaftliche Evidenz mit individuellen Bedürfnissen in Einklang zu bringen.

CytoSorbents unterstützt Ärztinnen und Ärzte weltweit bei dieser täglichen Gratwanderung – mit innovativen Lösungen zur Steuerung schwerer Entzündungsreaktionen.

🤝 Lassen Sie uns auf dem DIVI 2025 in Hamburg ins Gespräch kommen!
👉 https://www.divi25.de/

Address

305 College Road East
Princeton, NJ
08540

Website

http://www.cytosorbents.com/

Alerts

Be the first to know and let us send you an email when CytoSorbents posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CytoSorbents:

Want your practice to be the top-listed Clinic in Princeton?

CytoSorbents

12/01/2025

11/27/2025

11/27/2025

11/27/2025

11/26/2025

11/26/2025

11/25/2025

11/21/2025

11/21/2025

11/19/2025

11/18/2025

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category